Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures pharmaceutical formulations for the overseas.
Medicamen Biotech Limited, is a listed public company incorporated on 22 December, 1993. It is classified as a public limited company and is located in New Delhi, Delhi. It's authorized share capital is INR 15.00 cr and the total paid-up capital is INR 13.56 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Vimal Kumar Shrawat | 08274190 | 7 years |
| Ceo | Rajesh Madan | 07725345 | 10 years |
| Director | Sumita Dwivedi | 08218640 | 7 years |
| Director | Sangeeta Bishnoi | 08288998 | 7 years |
| Director | Ravi Kumar Bansal | 08462513 | 7 years |
| Director | Sanjay Bansal
Shareholder
|
00121667 | 11 years |
| Director | Ashwani Kumar Sharma | 00325634 | 11 years |
| Director | Suresh Kumar Singh | 00318015 | 11 years |
| Director | Rahul Bishnoi | 00317960 | 11 years |
| Director | Shaival Saurabh | 01971944 | 1 years |
| Director | Sham Goel | 02183287 | 1 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
IndusInd Bank Limited
No. of Loans: 3
Total Amount : 35.4 cr
CitiBank N.A.
No. of Loans: 1
Total Amount : 20.0 cr
HDFC Bank Limited
No. of Loans: 2
Total Amount : 10.3 cr
AU SMALL FINANCE BANK LIMITED
No. of Loans: 1
Total Amount : 9.0 cr
MERCEDES-BENZ FINANCIAL SERVICES INDIA PRIVATE LIMITED
No. of Loans: 2
Total Amount : 1.7 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| J B SPINTEX PRIVATE LIMITED |
Active
|
5.8 L | 1 | Delhi |
| VERSATILE LAND BASE PRIVATE LIMITED |
Active
|
8.0 L | 1 | Delhi |
| VERSATILE TECHCON PRIVATE LIMITED |
Active
|
13.2 L | 1 | Delhi |
| GENIUS CONSTRUCTIONS PRIVATE LIMITED |
Active
|
5.5 L | 1 | Delhi |
| SM POLYTEX PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Delhi |
| SHIVALIK RASAYAN LIMITED |
Active
|
7.9 Cr | 10 | Uttarakhand |
| MEDICAMEN LIFE SCIENCES PRIVATE LIMITED |
Active
|
4.0 Cr | 2 | Delhi |
| GROWEL REMEDIES LIMITED |
Active
|
24.6 L | 2 | Delhi |
| MINDCUBE DESIGN PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| ESSEM MERCANTILE LIMITED |
Active
|
51.0 L | 1 | Delhi |
| GARNE THREADS PRIVATE LIMITED |
Active
|
12.8 L | 1 | Delhi |
| CHEM PHARMA HEALTHCARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
Read more
The incorporation date of MEDICAMEN BIOTECH LIMITED is 22 December, 1993
The authorized share capital of MEDICAMEN BIOTECH LIMITED is INR ₹ 15.0 Cr.
The paid-up capital of MEDICAMEN BIOTECH LIMITED is INR ₹ 13.6 Cr.
The registered address of MEDICAMEN BIOTECH LIMITED is 1506, Chiranjiv Tower, 43, Nehru Place New Delhi Delhi - 110019
The CIN number of MEDICAMEN BIOTECH LIMITED is L74899DL1993PLC056594.